Revance Therapeutics (RVNC)
NASDAQ:RVNC
Holding RVNC?
Track your performance easily

Revance Therapeutics (RVNC) Ownership - Who Owns Revance Therapeutics?

605 Followers

Revance Therapeutics (RVNC) Ownership Overview

12.88%37.09%48.35%1.68%
12.88% Insiders
48.35% Other Institutional Investors
1.68% Public Companies and
Individual Investors
The ownership structure of Revance Therapeutics (RVNC) stock is a mix of institutional, retail and individual investors. Approximately 85.44% of the company’s stock is owned by Institutional Investors, 12.88% is owned by Insiders and 1.68% is owned by Public Companies and Individual Investors.
The ownership structure of Revance Therapeutics (RVNC) stock is a mix of institutional, retail and individual investors. Approximately 85.44% of the company’s stock is owned by Institutional Investors, 12.88% is owned by Insiders and 1.68% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 17, 2024
Erica Jordan
Chief Commercial Officer
xxxxxxxxxxxxx
$9090
Mar 19, 2024
xxxxxxxxxxxxx
$67436
Mar 19, 2024
Dwight Moxie
Clo & Gc
xxxxxxxxxxxxx
$58276
Mar 19, 2024
xxxxxxxxxxxxx
$62149

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$1072103

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,384,192Institution7.09%44,046,705
6,334,383Institution6.08%37,784,595
5,458,829Institution5.24%32,561,915
5,243,094Institution5.03%31,275,056
4,523,634Institution4.34%26,983,477
3,096,650Insider2.97%18,471,517
3,096,650Insider2.97%18,471,517
3,096,650Insider2.97%18,471,517
3,030,752Institution2.91%18,078,436
1,845,529Institution1.77%11,008,580

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,384,192Institution7.09%44,046,705
6,334,383Institution6.08%37,784,595
4,523,634Institution4.34%26,983,477
3,030,752Institution2.91%18,078,436
1,845,529Institution1.77%11,008,580
1,443,571Institution1.39%8,610,901
936,581Institution0.90%5,586,706
920,730Institution0.88%5,492,154
905,194Institution0.87%5,399,482
882,402Institution0.85%5,263,528

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,775,000Institution2.66%16,552,875
3,094,072Institution2.97%11,695,592
1,514,464Institution1.45%5,724,674
911,002Institution0.87%5,434,127
687,442Institution0.66%4,100,592
494,764Institution0.47%2,953,741
266,571Institution0.26%1,590,096
408,829Institution0.39%1,545,374
242,635Institution0.23%1,447,318
227,124Institution0.22%1,354,795

FAQ

Who Owns Revance Therapeutics (RVNC)?
According to the latest TipRanks data, approximately 48.35% of the company's stock is held by institutional investors, 12.88% is held by insiders, and 1.68% is held by retail investors.
    What percentage of Revance Therapeutics (RVNC) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 48.35% of Revance Therapeutics (RVNC) stock is held by institutional investors.
      What percentage of Revance Therapeutics (RVNC) stock is held by retail investors?
      According to the latest TipRanks data, approximately 1.68% of Revance Therapeutics (RVNC) stock is held by retail investors.
        Who owns the most shares of Revance Therapeutics (RVNC)?
        SMALLCAP World Fund Inc owns the most shares of Revance Therapeutics (RVNC).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis